Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
On Thursday, a dozen Senate Democrats proposed a framework for private health insurance with the goal of making it affordable ...
The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
Meanwhile, a Jennifer Doudna-founded company is edging toward successful CAR-T therapy done in vivo, and a “triple-G” drug from Eli Lilly delivers strong results. Lastly, don’t forget that today is ...
In today's Morning Rounds newsletter: the precarious state of U.S. science, what we take for granted about vaccines, and more.
Nursing homes misuse antipsychotic drugs for dementia patients, disguise practice as schizophrenia treatment, watchdog finds.
Adam Sherwat, the director of the office of infectious diseases in the FDA’s Center for Drug Evaluation and Research, is ...
The Covid-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that ...
STAT interviews with 30 respondents brought the unmistakably human impacts of federal science policy into sharp focus. Here are three of those stories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results